NF-κB and AP-1 regulate activation-dependent CD137 (4-1BB) expression in T cells

被引:46
|
作者
Kim, JO
Kim, HW
Baek, KM
Kang, CY [1 ]
机构
[1] Seoul Natl Univ, Coll Pharm, Immunol Lab, Seoul 151742, South Korea
[2] Seoul Natl Univ, Coll Pharm, Res Inst Pharmaceut Sci, Seoul 151742, South Korea
关键词
4-1BB; CD137; T cell activation; T cell receptor signal; transcription factor;
D O I
10.1016/S0014-5793(03)00326-0
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
4-1BB(CD137) is a member of the tumor necrosis factor receptor superfamily and provides a costimulatory signal by interaction with 4-1BB ligand expressed on antigen-presenting cells. The expression of 4-1BB is known to be activation-dependent. Here, we investigated the transcriptional machinery required for T cell receptor (TCR) activation-dependent induction of 4-1BB expression in CD3-CEM cells treated with phorbol myristate acetate and ionomycin. Using 5'-deletion constructs of 4-1BB promoter in luciferase reporter assays, we demonstrated that the transcriptional elements mediating 4-1BB upregulation were located in the region between similar to 0.9 and similar to 1.1 kb from the translational start site. Characterization of these sites by electrophoretic mobility shift assay and site-directed mutagenesis revealed that nuclear factor kappaB (NF-kappaB) and activating protein-1 (AP-1) are involved. MEK and c-Jun N-terminal kinase-1 activity was required for activation-dependent 4-1BB upregulation. Thus, NF-kappaB and AP-1 are involved in the TCR stimulation-dependent transcriptional regulation of the 4-1BB promoter. (C) 2003 Federation of European Biochemical Societies. Published by Elsevier Science B.V. All rights reserved.
引用
收藏
页码:163 / 170
页数:8
相关论文
共 50 条
  • [21] Functional expression of 4-1BB (CD137) in the inflammatory tissue in Crohn's disease
    Maerten, P
    Geboes, K
    De Hertogh, G
    Shen, C
    Cadot, P
    Bullens, DMA
    Van Assche, G
    Penninckx, F
    Rutgeerts, P
    Ceuppens, JL
    CLINICAL IMMUNOLOGY, 2004, 112 (03) : 239 - 246
  • [22] Assessing CD137 (4-1BB) As a Therapeutic Target in B-Cell Neoplasms
    Cohen, Adam D.
    Joshi, Indira D.
    Robu, Valentin
    Borghaei, Hossein
    Al-Saleem, Tahseen I.
    Jure-Kunkel, Maria
    Smith, Mitchell R.
    BLOOD, 2011, 118 (21) : 1594 - 1595
  • [23] Immunity in the absence of CD28 and CD137 (4-1BB) molecules
    Vinay, DS
    Wolisi, GO
    Yu, KY
    Choi, BK
    Kwon, BS
    IMMUNOLOGY AND CELL BIOLOGY, 2003, 81 (03): : 176 - 184
  • [24] CD137 (4-1BB) Deficiency Reduces Atherosclerosis in Hyperlipidemic Mice
    Jeon, Hyung Jun
    Choi, Jae-Hoon
    Jung, In-Hyuk
    Park, Jong-Gil
    Lee, Mi-Ran
    Lee, Mi-Ni
    Kim, Bora
    Yoo, Ji-Young
    Jeong, Se-Jin
    Kim, Dae-Yong
    Park, Jeong Euy
    Park, Hyun-Young
    Kwack, KyuBum
    Choi, Beom Kyu
    Kwon, Byoung S.
    Oh, Goo Taeg
    CIRCULATION, 2010, 121 (09) : 1124 - U126
  • [25] Galectin-9 controls the activity of 4-1BB (CD137)
    Madireddi, Shravan
    Eun, So-Young
    Mehta, Amit
    Nemcovicova, Ivana
    Lee, Seung-Woo
    Niki, Toshiro
    Hirashima, Mitsuomi
    Zajonc, Dirk
    Croft, Michael
    JOURNAL OF IMMUNOLOGY, 2013, 190
  • [26] The promise of 4-1BB (CD137)-mediated immunomodulation and the immunotherapy of cancer
    Lynch, David H.
    IMMUNOLOGICAL REVIEWS, 2008, 222 : 277 - 286
  • [27] The ligand for 4-1BB (CD137) is functionally expressed on freshly isolated human Langerhans cells
    Péguet-Navarro, C
    Dalbiez-Gauthier, C
    Grousson, J
    Schmitt, D
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2000, 114 (01) : 221 - 221
  • [28] Mitochondria! Morphological and Functional Reprogramming Following CD137 (4-1BB) Costimulation
    Teijeira, Alvaro
    Labiano, Sara
    Garasa, Saray
    Etxeberria, Inaki
    Santamaria, Eva
    Rouzaut, Ana
    Enamorado, Michel
    Azpilikueta, Arantza
    Inoges, Susana
    Bolanos, Elixabet
    Angela Aznar, Maria
    Sanchez-Paulete, Alfonso R.
    Sancho, David
    Melero, Ignacio
    CANCER IMMUNOLOGY RESEARCH, 2018, 6 (07) : 798 - 811
  • [29] CD137 (ILA/4-1BB), expressed by primary human monocytes, induces monocyte activation and apoptosis of B lymphocytes
    Kienzle, G
    von Kempis, J
    INTERNATIONAL IMMUNOLOGY, 2000, 12 (01) : 73 - 82
  • [30] The promise of 4-1BB (CD137) mediated immunomodulation and immunotherapy for viral diseases
    Rahman, Md Masudur
    Badruzzaman, A. T. M.
    Hossain, Ferdaus Mohd Altaf
    Husna, Asmaul
    Bari, Abusaleh Mahfuzul
    Eo, Seong Kug
    FUTURE VIROLOGY, 2017, 12 (07) : 361 - 372